1. Home
  2. ENOV vs BHC Comparison

ENOV vs BHC Comparison

Compare ENOV & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • BHC
  • Stock Information
  • Founded
  • ENOV 1995
  • BHC N/A
  • Country
  • ENOV United States
  • BHC Canada
  • Employees
  • ENOV N/A
  • BHC N/A
  • Industry
  • ENOV Fluid Controls
  • BHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENOV Industrials
  • BHC Health Care
  • Exchange
  • ENOV Nasdaq
  • BHC Nasdaq
  • Market Cap
  • ENOV 2.1B
  • BHC 2.0B
  • IPO Year
  • ENOV 2008
  • BHC N/A
  • Fundamental
  • Price
  • ENOV $31.56
  • BHC $4.45
  • Analyst Decision
  • ENOV Strong Buy
  • BHC Hold
  • Analyst Count
  • ENOV 5
  • BHC 5
  • Target Price
  • ENOV $58.00
  • BHC $7.20
  • AVG Volume (30 Days)
  • ENOV 1.1M
  • BHC 1.7M
  • Earning Date
  • ENOV 05-08-2025
  • BHC 04-30-2025
  • Dividend Yield
  • ENOV N/A
  • BHC N/A
  • EPS Growth
  • ENOV N/A
  • BHC N/A
  • EPS
  • ENOV N/A
  • BHC N/A
  • Revenue
  • ENOV $2,150,191,000.00
  • BHC $9,731,000,000.00
  • Revenue This Year
  • ENOV $8.13
  • BHC $3.71
  • Revenue Next Year
  • ENOV $6.19
  • BHC $5.03
  • P/E Ratio
  • ENOV N/A
  • BHC N/A
  • Revenue Growth
  • ENOV 18.32
  • BHC 8.53
  • 52 Week Low
  • ENOV $29.32
  • BHC $3.96
  • 52 Week High
  • ENOV $51.10
  • BHC $9.85
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 36.65
  • BHC 35.79
  • Support Level
  • ENOV $30.65
  • BHC $4.55
  • Resistance Level
  • ENOV $37.85
  • BHC $4.79
  • Average True Range (ATR)
  • ENOV 1.31
  • BHC 0.18
  • MACD
  • ENOV -0.32
  • BHC 0.01
  • Stochastic Oscillator
  • ENOV 12.64
  • BHC 6.25

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Share on Social Networks: